04.10.2022.

Maximon CSO talks clinics, diagnostics, and why longevity is about much more than drug development.

From companies developing longevity supplements and health analytics to skin aging therapies and longevity clinics, Maximon has already created an interesting stable of start-ups, with more yet to come. The company recently announced Dr Elisabeth Roider as its Chief Scientific and Medical Officer, as it builds out the senior team that oversees the companies in its portfolio. We caught up with Roider to learn more.